The Readout Loud
Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Rebecca Robbins of the New York Times joins us to discuss the escalating tension between Moderna and the National Institutes of Health over just who invented a Covid-19 vaccine. Then, STAT's Olivia Goldhill calls in to explain Compass Pathways' promising results using psilocybin as a treatment for depression and the future of the nascent field of psychedelic medicines. We also discuss the latest news in the life sciences, including pills for Covid-19, the next FDA commissioner, and whether Pfizer CEO Albert Bourla listens to Joe Rogan.